Inclusion Criteria:
  -  Patients diagnosed with Hunter syndrome
  -  Male at the age of â‰¥ 5
  -  Adequate abilities (including 6-MWT) to participate in this study in the opinion of the investigator.
  -  Voluntarily signed written informed consent to participation in this study
  -  Consent to contraception
Exclusion Criteria:
  -  Prior treatment with iduronate-2-sulfatase ERT
  -  History of bronchotomy, bone marrow trasplanation, or cord blood transplanation.
  -  Known hypersensitivity reactions to any of the components of the invetigational product
  -  Prior or planned administration of other investigational products within 30 days before treatment with the investigational product in this study or duirng this study.
  -  Unable to perform 6-MWT.
  -  Female